Zdravlje AD Leskovac announced today important organizational changes and new appointments which mark the beginning of the Company’s successful journey towards achieving Zdravlje’s Vision and Mission.
From today onwards, Kiren Naidoo will be taking over the role and responsibilities of Chief Executive Officer (CEO of Zdravlje AD Leskovac), with Levent Selamoglu appointed as Chairman of Zdravlje’s Board of Directors.
As of today, Zdravlje AD consists of three key Business Divisions which form the pillars of its future success:
Bojan Jovic will continue to successfully lead the Zdravlje Operations Division in Leskovac as Managing Director and Chief Operations Officer (MD & COO) directly reporting to Kiren Naidoo (CEO).
Dragan Cirkovic has joined the Team as Commercial Director and will lead Zdravlje’s Commercial Division, directly reporting to Kiren Naidoo (CEO).
Dragan Cirkovic is a Master of Pharmacy and Certified Marketing Executive who brings extensive industry experience and regional market knowledge to Zdravlje. Dragan has more than 17 years industry experience of which 8 years were spent at Meda Pharmaceuticals (a Sweden-based multinational specialty pharma company) where he was previously General Manager for the Balkan and Adriatic region (with responsibility for 10 markets across ex-Yugoslavia, Romania & Albania). Dragan will be responsible for building Zdravlje’s commercial platform comprising a high-value product portfolio, strong Zdravlje brand and wide export network.
"I am very excited to be joining Zdravlje, a company with a great heritage and one of the best brands in the Healthcare industry in the region. Over the course of more than six decades, Zdravlje established itself as a highly reliable supplier of medicines, on multiple international markets, all in line with local, EU, and global GMP standards. Throughout its history, Zdravlje established successful partnerships with some of the biggest pharma companies in the world today which is a testament to its quality and good-standing. After Frontier's acquisition of Zdravlje, I am looking forward to taking part in the new chapter of the company's history. Our main aim will be to increase access to high-quality medicines to patients, as well as to provide innovative medications in the most cost-effective way, both from our work-of-art manufacturing site and in partnership with international pharma companies."
“We are very pleased to welcome Dragan to our Team. We are confident that Dragan possesses the expertise to build and lead a top-performing commercial organization which is critical to the future success of Zdravlje.” said Kiren Naidoo, CEO of Zdravlje.
As part this important organization change, Zdravlje announced the establishment of its Business Development Division. This division will be responsible for generating new business opportunities across Zdravlje’s Operations and Commercial divisions. To support these efforts, Zdravlje welcomes Todor Nyagolov as its Senior Business Development Advisor. Todor is an experienced pharmaceutical executive with an extensive track record at PharmaScience (Canadian specialty pharma company) & Actavis (now Teva).
These changes are amongst the most significant developments in the history of Zdravlje and will strongly position the Company for its future growth. Zdravlje employees join in welcoming Dragan & Todor to the team and wish them all the best for their roles.